The Utility of p16INK4a and Ki-67 as a Conjunctive Tool in Uterine Cervical Lesions
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Immunohistochemical staining for p16INK4a and Ki-67 has been used to improve the accuracy in making a diagnosis of the uterine cervix cancer on biopsy. This study was conducted to examine the usefulness of these markers in the pathological diagnosis based on cervical biopsy. Methods: We selected a consecutive series of 111 colposcopically directed cervical punch biopsies. Using these biopsy samples, we performed an immunohistochemical staining for p16INK4a and Ki-67 to establish a diagnosis. The slides were circulated among four pathologists in a sequential order: the hematoxylin and eosin (H&E) slide, H&E slide and p16INK4a-stained slide, and H&E slide, p16INK4a- and Ki-67-stained slides. Results: The overall rates of the concordance in the first, the second, and the third diagnoses were 77.5%, 82.0%, and 82.0%, respectively. The rate of the concordance in the diagnosis of cervical intraepithelial neoplasm (CIN) 2/3 was increased from 62.2% to 73.0%. But there was a variability in the rate of the revision of the diagnosis between the pathologists. With the application of criteria for interpreting the expressions of p16INK4a and Ki-67, benign and CIN 1 lesions showed a p16INK4a expression score of 0 or 1. But CIN 2 and CIN 3 lesions showed a p16INK4a expression score of 2 and 3, respectively. Conclusions: The immunostain for p16INK4a and Ki-67 might be useful in reducing an inter-observer variability. But criteria for interpreting both markers should be strictly applied.
Abstract
Background: Immunohistochemical staining for p16INK4a and Ki-67 has been used to improve the accuracy in making a diagnosis of the uterine cervix cancer on biopsy. This study was conducted to examine the usefulness of these markers in the pathological diagnosis based on cervical biopsy. Methods: We selected a consecutive series of 111 colposcopically directed cervical punch biopsies. Using these biopsy samples, we performed an immunohistochemical staining for p16INK4a and Ki-67 to establish a diagnosis. The slides were circulated among four pathologists in a sequential order: the hematoxylin and eosin (H&E) slide, H&E slide and p16INK4a-stained slide, and H&E slide, p16INK4a- and Ki-67-stained slides. Results: The overall rates of the concordance in the first, the second, and the third diagnoses were 77.5%, 82.0%, and 82.0%, respectively. The rate of the concordance in the diagnosis of cervical intraepithelial neoplasm (CIN) 2/3 was increased from 62.2% to 73.0%. But there was a variability in the rate of the revision of the diagnosis between the pathologists. With the application of criteria for interpreting the expressions of p16INK4a and Ki-67, benign and CIN 1 lesions showed a p16INK4a expression score of 0 or 1. But CIN 2 and CIN 3 lesions showed a p16INK4a expression score of 2 and 3, respectively. Conclusions: The immunostain for p16INK4a and Ki-67 might be useful in reducing an inter-observer variability. But criteria for interpreting both markers should be strictly applied.
참고문헌 (27)
- Wright TC Jr, "2001 Consensus guidelines for the management of women with cervical cytological abnormalities", JAMA, 287, pp.2120~2129 (2002)
- Kalof AN, "p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia", Adv Anat Pathol, 13, pp.190~194 (2006)
- Klaes R, "p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia", Am J Surg Pathol, 26, pp.1389~1399 (2002)
- Tringler B, "Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia", Hum Pathol, 35, pp.689~696 (2004)
- Keating JT, "Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis", Adv Anat Pathol, 8, pp.83~92 (2001)
- Sano T, "Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions", Am J Pathol, 153, pp.1741~1748 (1998)
- O’Neill CJ, "p16 expression in the female genital tract and its value in diagnosis", Adv Anat Pathol, 13, pp.8~15 (2006)
- Horn LC, "Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia", Am J Surg Pathol, 32, pp.502~512 (2008)
- McCluggage WG, "Immunohistochemistry as a diagnostic aid in cervical pathology", Pathology, 39, pp.97~111 (2007)
- Klaes R, "Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri", Int J Cancer, 92, pp.276~284 (2001)
- Agoff SN, "p16 (INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types", Mod Pathol, 16, pp.665~673 (2003)
- Murphy N, "p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer", J Clin Pathol, 58, pp.525~534 (2005)
- Mulvany NJ, "Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies", Pathology, 40, pp.335~344 (2008)
- Nielsen GP, "Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues", Lab Invest, 79, pp.1137~1143 (1999)
- Guenova M, "p16INK4A is regularly expressed in Hodgkin’s disease: comparison with retinoblastoma, p53 and MDM2 protein status, and the presence of Epstein-Barr virus", Mod Pathol, 12, pp.1062~1071 (1999)
- Vo QN, "Schneider BG. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables", Hum Pathol, 33, pp.1200~1204 (2002)
- Leversha MA, "Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays", J Pathol, 200, pp.610~619 (2003)
- Rocco JW, "p16(MTS-1", CDKN2, Exp Cell Res, pp.2001, 264[DOI]
- Beasley MB, "The P16", cyclin D1, Hum Pathol, pp.2003, 34[DOI]
- Murphy N, "p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears", J Clin Pathol, 56, pp.56~63 (2003)
- Stanley MA., "Prognostic factors and new therapeutic approaches to cervical cancer", Virus Res, 89, pp.241~248 (2002)
- Stoler MH, "Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study", JAMA, 285, pp.1500~1505 (2001)
- 이종실, "자궁목 병변에서 p16, p53 단백과 Ki-67의 발현", The Korean Journal of Pathology, 38(4), pp.238~243 (2004), 대한병리학회
- Dray M, "p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies", Pathology, 37, pp.112~124 (2005)
- Wang SS, "Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica", Cancer Epidemiol Biomarkers Prev, 13, pp.1355~1360 (2004)
- Hariri J, "The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix", Int J Gynecol Pathol, 26, pp.223~228 (2007)
- Konishi I, "Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix", Cancer, 68, pp.1340~1350 (1991)